Polypharmacy Because of Multimorbidity in Geriatric Nursing Home Residents
Conditions
Brief summary
Nursing home residents are among the frailest patient groups with a high number of co-morbidities and a high use of medicines. Inappropriate polypharmacy (i.e. often overprescribing) is one of the major problems in the nursing home population increasing the number of adverse drug reactions, falls, hospital admissions, mortality as well as having an impact on health care utilization. Multidisciplinary medication reviews have a great potential to reduce inappropriate medication use. The purpose of this study is to determine the efficacy of a multidisciplinary medication review model focussing on discontinuing inappropriate medication in a cluster randomized controlled trial in 600 nursing home residents. The primary outcome measure is the difference in proportion of residents who successfully discontinued medication between intervention and control group after four months. Secondary outcome measures will be the drug burden index, adverse drug withdrawal events related to the discontinued medication, death, referral to hospitals and quality of life.
Interventions
PROCEDUREMultidisciplinary medication review
Consists of the following steps: * 1\. Elderly care physician and nursing staff evaluate with the patient the experience of taking medicines, adverse drug reactions and patient's preferences. * 2\. Pharmacist reviews medication to identify drug related problems using START/STOPP en Beers criteria. * 3/4. Meeting of elderly care physician, pharmacist. Possibilities to discontinue prescribed medication will be examined resulting in pharmaceutical care plan that optimizes the patient's medication i.e. which inappropriate medication should be discontinued following a prioritization and time schedule. * 5\. Execution of pharmaceutical care plan according to agreed schedule.
Sponsors
ZonMw: The Netherlands Organisation for Health Research and Development
University of Groningen
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
Nursing Home Wards: Inclusion criteria: * Long stay ward * Capability and commitment to perform a multidisciplinary multistep medication review.
Exclusion criteria
* Short stay, revalidation or observation wards * Specialized ward where patients with an atypical etiology are cared for. * Elderly care physicians who have recently received or who are to receive recertification at short notice with regard to systematic medication review methodology. * Participation in other studies aimed at improving the quality of drug prescription (in the past 12 months). Nursing Home Residents: Inclusion criteria: * A life expectancy of \>4 weeks as judged by the treating elderly care physician. * IC provided by patients themselves or provided by a legal representative for incapacitated patients.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Successful medication discontinuation | 4 months | The number of residents for whom ≥1 inappropriate medication(s) are succesfully discontinued i.e. without relapse or severe withdrawal effects |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Medication initiation | 4 months | Number of residents for whom ≥1 medication(s) are initiated (s) that should be started on the basis of the Screening Tool to Alert doctors to Right Treatment (START) criteria |
| Dose adjustment | 4 months | Number of residents for whom ≥1 dose(s) are lowered or increased |
| Safer alternative medication | 4 months | The percentage of residents for whom ≥1 medication(s) is replaced by a safer alternative |
| Drug burden index | 4 months | A measure of a person's cumulative exposure to anticholinergic and sedative medications, which has been associated with falls in nursing home patients |
| Quality of Life | 4 months | Quality of life will be measured using a disease specific instrument (DQI (Scholzel-Dorenbosch et al, in press) and a generic instrument EQ-5D-5L for all patients (Herdman et al, 2011). |
| adverse drug withdrawal events | 4 months | The rate of adverse drug withdrawal events related to the discontinued medication |
| Bone fractures | 4 months | Bone fractures caused by falling |
| number of visits to outpatient clinics / emergency rooms / by medical consultants | 4 months | number of visits to outpatient clinics, emergency rooms, number of visits by medical consultants i.e. physicians who visit the patients in the nursing homes, |
| Death | 4 months | Incidence of death |
| Hospital admission | 4 months | Hospital admission |
| Falling | 4 months | Defined as any event in which a nursing home resident touches the ground in an unintentional sudden manner without cues of emergency |
Other
| Measure | Time frame | Description |
|---|---|---|
| Cognitive function | 4 months | Cognitive function as assessed with standardized cognitive tests called the Severe Impairment Battery and the Mini Mental Status Examination |
| Neuropsychiatric Symptoms | 4 months | Assessment of change in neuropsychiatric symptoms (e.g. hallucinations & delusions) with the Neuropsychiatric Inventory (NPI) (nursing home version). |
Countries
Netherlands
Outcome results
None listed